Drug Profile
Research programme: histone methyltransferase inhibitors - Chroma Therapeutics
Alternative Names: Histone methyltransferase inhibitors research programme - Chroma TherapeuticsLatest Information Update: 15 May 2008
Price :
$50
*
At a glance
- Originator Chroma Therapeutics
- Class Small molecules
- Mechanism of Action Histone methyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 09 Mar 2005 Preclinical trials in Cancer in United Kingdom (unspecified route)